|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| C07K 16/30 | |||
| A61P 35/00 | |||
| A61K 39/395 | |||
| A61K 9/00 | |||
| A61K 47/02 | |||
| A61K 47/12 | |||
| A61K 47/26 | |||
| A61K 39/00 |
| (11) | Number of the document | 3116908 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15709212.3 |
| Date of filing the European patent application | 2015-03-12 | |
| (97) | Date of publication of the European application | 2017-01-18 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/055224 |
| Date | 2015-03-12 |
| (87) | Number | WO 2015/136052 |
| Date | 2015-09-17 |
| (30) | Number | Date | Country code |
| 201461953035 P | 2014-03-14 | US |
| (72) |
GAUTHIER, Laurent, FR
SCHNEIDER, Nicolas, FR
|
| (73) |
Innate Pharma,
117, Avenue de Luminy, 13009 Marseille,
FR
|
| (54) | HUMANIZED KIR3DL2 ANTIBODIES |
| HUMANIZED KIR3DL2 ANTIBODIES |